The effective of the triple therapy for clarithromycin-resistant Helicobacter pylori using Vonoprazan,AMPC,MNZ.

The effective of the triple therapy for clarithromycin-resistant Helicobacter pylori using Vonoprazan,AMPC,MNZ. - Eradication therapy for CAM-resistant Helicobacter pylori.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000021418

Enrollment

200

Registered

2016-03-10

Start date

2016-03-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Helicobacter pylori infected patient

Exclusion criteria

Exclusion criteria: Penicillin allergy

Design outcomes

Primary

Measure	Time frame
eradication rate	—

Countries

Japan

Contacts

Public ContactHisatsugu Noda

Aichi medical university gastroenterology

bisaipan@aichi-med-u.ac.jp0561-62-3311

Outcome results